ASMB Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 mai 2024 @ 22:00):

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States...

Stats
Dagens volum	23 422.00
Gjennomsnittsvolum	19 495.00
Markedsverdi	82.48M
EPS	$0 ( 2024-05-09 )
Neste inntjeningsdato	( $-3.23 ) 2024-05-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.120
ATR14	$0.106 (0.71%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	White Nicole S	Buy	3 333	Common Stock
2024-04-30	White Nicole S	Sell	1 255	Common Stock
2024-04-29	Okazaki Jason A	Buy	4 166	Common Stock
2024-04-30	Okazaki Jason A	Sell	1 569	Common Stock
2024-04-29	Delaney William E Iv	Buy	3 333	Common Stock

INSIDER POWER
65.17
Last 96 transactions
Buy: 3 858 062 \| Sell: 644 587

Volum Korrelasjon

Lang: 0.14 (neutral)

Kort: -0.30 (neutral)

Signal:(55.621) Neutral

Assembly Biosciences Inc Korrelasjon

10 Mest positive korrelasjoner
KBWP	0.917
BUFF	0.909
DVOL	0.906
TARS	0.906
CRDL	0.903
FNILX	0.896
DXJS	0.896
MMYT	0.896
CDRO	0.895
FLXS	0.893

10 Mest negative korrelasjoner
GP	-0.911
MYMD	-0.891
SINT	-0.891
TBLT	-0.89
AGRX	-0.889
AGFY	-0.884
RIVN	-0.883
WW	-0.882
ACON	-0.882
FLGT	-0.88

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Assembly Biosciences Inc Korrelasjon - Valuta/Råvare

-0.16
( neutral )

-0.14
( neutral )

0.00
( neutral )

-0.27
( neutral )

-0.35
( neutral )

-0.40
( neutral )

Assembly Biosciences Inc Økonomi

Annual	2023
Omsetning:	$7.16M
Bruttogevinst:	$6.71M (93.72 %)
EPS:	$-13.38

FY	2023
Omsetning:	$7.16M
Bruttogevinst:	$6.71M (93.72 %)
EPS:	$-13.38

FY	2022
Omsetning:	$0
Bruttogevinst:	$-498 000 (0.00 %)
EPS:	$-22.82

FY	2021
Omsetning:	$6.25M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.67

Financial Reports:

No articles found.

Assembly Biosciences Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Assembly Biosciences Inc

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.